Evidence map›Paper›PMID 40523885›Full record

ArticleBone research2025

Membrane-initiated estrogen receptor-α signaling in osteoblasts is crucial for normal regulation of the cortical bone in female mice.

Yiwen Jiang, Karin Horkeby, Petra Henning, Jianyao Wu, Karin H Nilsson, Lina Lawenius, Sofia Movérare-Skrtic, Priti Gupta, Cecilia Engdahl, Antti Koskela and 4 more

Abstract read
In one paragraph

Article in Bone research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yiwen Jiang *Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Karin Horkeby *Sahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden. karin.horkeby@gu.se.
Petra HenningSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-9330-6265
Jianyao WuSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Karin H NilssonSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Lina LaweniusSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Sofia Movérare-SkrticSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.ORCID http://orcid.org/0000-0001-7982-7438
Priti GuptaSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Cecilia EngdahlSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Antti KoskelaDepartment of Anatomy and Cell Biology, Faculty of Medicine, Translational Medicine Research Unit, University of Oulu, FI-90014, Oulu, Finland.
Juha TuukkanenDepartment of Anatomy and Cell Biology, Faculty of Medicine, Translational Medicine Research Unit, University of Oulu, FI-90014, Oulu, Finland.
Lei LiSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.
Claes OhlssonSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-9633-2805
Marie K LagerquistSahlgrenska Osteoporosis Centre, Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, S-41346, Gothenburg, Sweden.

Funding

IngaBritt och Arne Lundbergs Forskningsstiftelse (Ingabritt and Arne Lundberg Research Foundation) LU2017-0076Novo Nordisk Fonden (Novo Nordisk Foundation) 26844Stiftelsen Konung Gustaf V:s 80-årsfond (King Gustaf V's 80-year Foundation) FAI-2018-0466Vetenskapsrådet (Swedish Research Council) 2017-01286Vetenskapsrådet (Swedish Research Council) 2020-01840
6 · The paper itself

Abstract

Membrane-initiated estrogen receptor α (mERα) signaling has been shown to affect bone mass in murine models. However, it remains unknown which cell types mediate the mERα-dependent effects on bone. In this study, we generated a novel mouse model with a conditional C451A mutation in Esr1, which enables selective knockout of the palmitoylation site essential for the membrane localization of ERα (C451A

Indexed as

Cell MembraneCortical BoneEstrogen Receptor alphaOsteoblastsSignal TransductionAnimalsCell DifferentiationFemaleMiceX-Ray MicrotomographyEstrogen Receptor alpha

Identifiers

PMID40523885
PMCPMC12170823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.